This new knowledge provides more options for developing psychedelics into therapeutic drug formulations.
The center aims to quantify the chemicals in magic mushrooms and possibly identify new psychedelic molecules in them.
Market introduction of psychedelics as a therapy looks promising. However, policy and regulatory issues concerning the drug class still exist.
This is the first time psilocybin has been produced from a prokaryotic organism.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.
Psilacetin is easier and less expensive to make than psilocybin, but much of its pharmacology is unknown.
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.
A 2014 study showed that psilocybin opens up communication between areas of the human brain that don't normally talk to each other.
The center is the first of its kind in the US and will propel psychedelic research to a new level.
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.